62 results
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
.
“Pharmaceutical Product” shall have the meaning ascribed to such term in Section 3.1(hh).
“Proceeding” means an action, claim, suit, investigation … or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
S-8
EX-5.1
MAIA
MAIA Biotechnology Inc
19 Apr 24
Registration of securities for employees
4:01pm
investigation. We have made such other investigations as we have deemed relevant and necessary in connection with the opinions hereinafter set forth
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
.
“Pharmaceutical Product” shall have the meaning ascribed to such term in Section 3.1(hh).
“Proceeding” means an action, claim, suit, investigation … or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
8-K
EX-10.1
1yep12s vxku0
13 Mar 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
koyz4 pxizmb3
6 Mar 24
Other Events
8:00am
424B5
ezyok05tn9okf
14 Feb 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-1.1
8epnr
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
nwcs1m8rwy2
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
424B5
dhxxj38spdmjis21tq
17 Nov 23
Prospectus supplement for primary offering
9:06am
8-K
EX-4.1
9bua29043 bw4gu
16 Nov 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
s90kjx
7 Nov 23
MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIO
8:05am
8-K
EX-99.2
zv5ly65hbe 91
30 Oct 23
Other Events
5:24pm
8-K
EX-5.1
pfrlu2
1 Sep 23
Entry into a Material Definitive Agreement
4:45pm
8-K
EX-10.1
ntyube83oqvof9t
1 Sep 23
Entry into a Material Definitive Agreement
4:45pm
424B5
ip1yxspxqwb37
1 Sep 23
Prospectus supplement for primary offering
4:30pm
S-3
EX-4.5
q1xg2e d4z
14 Aug 23
Shelf registration
6:05pm
S-3
gwwyr94n4
14 Aug 23
Shelf registration
6:05pm
S-3
EX-4.6
j6qu6o9 jq6
14 Aug 23
Shelf registration
6:05pm